Skip to content

Clinical trials

Psychotic Disorders trials in Poland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Psychotic Disorders Country / region: Poland Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20042
20051
20071
20112
20173
20221
20243
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Recruiting3
Unknown status2
Not yet recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Alkermes, Inc.2
ACADIA Pharmaceuticals Inc.1
Eli Lilly and Company1
Intra-Cellular Therapies, Inc.1
Janssen Research & Development, LLC1
Janssen-Cilag International NV1
Karuna Therapeutics, Inc., a Bristol Myers Squibb company1
MapLight Therapeutics1
Medical University of Lodz1
Polish Academy of Sciences1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Psychotic Disorders14
Schizophrenia8
Alzheimer Disease4
Dementia2
Hallucinations2
Schizophrenia Spectrum and Other Psychotic Disorders2
Brain Diseases1
Central Nervous System Diseases1
Corticobasal Degeneration1
Dementia, Vascular1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.